Inquiries · Recommendations

Public Inquiry Recommendations

1,814 tracked recommendations 35 inquiries 638 match current filters Page 7 of 13

Recommendations issued by UK statutory and non-statutory inquiries, with their tracked government response and supporting evidence.

Clear

Browse by inquiry

35 inquiries with tracked recs
Inquiry Recs Accepted
Mid Staffs Inquiry 290 281
Manchester Arena Inquiry 169 169
IICSA 107 96
Muckamore Abbey Inquiry 106
Grenfell Tower Inquiry 104 104
Infected Blood Inquiry 103 102
Hyponatraemia Inquiry 96 95
Fuller Inquiry 92 71
Leveson Inquiry 92 77
Vale of Leven Inquiry 75 75
Baha Mousa Inquiry 73 72
Southport Inquiry 67
RHI Inquiry 45 44
COVID-19 Inquiry 44 19
Morecambe Bay Investigation 44 44
Brook House Inquiry 33 28
Bichard Inquiry 31 31
Angiolini Inquiry 30 16
Post Office Horizon Inquiry 27 25
Jermaine Baker Inquiry 26 22
Edinburgh Tram Inquiry 24 21
Daniel Morgan Panel 23 23
Cranston Inquiry 18
Paterson Inquiry 17 15
HIA Inquiry 12 12
Scottish Hospitals Inquiry 11 11
Anthony Grainger Inquiry 9 9
Al-Sweady Inquiry 9 9
Hillsborough Panel 9 5
Fingerprint Inquiry 9 9
ICL Inquiry 7 6
Litvinenko Inquiry 5 5
Azelle Rodney Inquiry 3 3
Billy Wright Inquiry 3 3
Penrose Inquiry 1 1

Recommendations

638 of 1,814 · page 7 of 13
Code Recommendation Inquiry Response
IBI-7a(i) Transfusion Committees and Tranexamic Acid - England
In England, Hospital Transfusion Committees and transfusion practitioners take steps to ensure that consideration of tranexamic acid be on every hospital surgical …
Infected Blood Inquiry (2024) Accepted in Part
IBI-7a(ii) Tranexamic Acid - Scotland, Wales and NI
In Scotland, Wales and Northern Ireland offering the use of tranexamic acid should be considered a treatment of preference in respect of …
Infected Blood Inquiry (2024) Accepted
IBI-7a(iii) Transfusion Performance Benchmarking
Consideration be given to standardising and benchmarking transfusion performance between hospitals in order to deliver better patient blood management
Infected Blood Inquiry (2024) Accepted
IBI-7b Transfusion 2024 Review Progress
Review of progress towards the Transfusion 2024 recommendations: Progress in implementation of the Transfusion 2024 recommendations be reviewed, and next steps be …
Infected Blood Inquiry (2024) Accepted
IBI-7c Transfusion Laboratory Staffing
Transfusion laboratories: Transfusion laboratories should be staffed (and resourced) adequately to meet the requirements of their functions.
Infected Blood Inquiry (2024) Accepted in Part
IBI-7d Training in Transfusion Medicine
Training in Transfusion Medicine: That those bodies concerned with undergraduate and postgraduate training across the UK of those people who are, or …
Infected Blood Inquiry (2024) Accepted in Part
IBI-7e Implementing SHOT Reports
Implementing SHOT reports: That all NHS organisations across the UK have a mechanism in place for implementing recommendations of Serious Hazard of …
Infected Blood Inquiry (2024) Accepted in Part
IBI-7f(i) Transfusion Outcome Framework
Establishing the outcome of every transfusion: That a framework be established for recording outcomes for recipients of blood components. That those records …
Infected Blood Inquiry (2024) Accepted
IBI-7f(ii) NHSBT Transfusion Outcome Funding
Establishing the outcome of every transfusion: To the extent that the funding for digital transformation does not already cover the setting up …
Infected Blood Inquiry (2024) Accepted
IBI-7f(iii) Blood Tracking Systems Funding
Establishing the outcome of every transfusion: That funding for the provision of enhanced electronic clinical systems in relation to blood transfusion be …
Infected Blood Inquiry (2024) Accepted in Part
IBI-8a Pre-1996 Transfusion Testing
When doctors become aware that a patient has had a blood transfusion prior to 1996, that patient should be offered a blood …
Infected Blood Inquiry (2024) Accepted
IBI-8b New Patient Registration Screening
As a matter of routine, new patients registering at a practice should be asked if they have had such a transfusion.
Infected Blood Inquiry (2024) Accepted
IBI-9a Haemophilia Peer Review
That peer review of haemophilia care should continue to occur as presently practised, with any necessary support being provided by NHS Trusts …
Infected Blood Inquiry (2024) Accepted
IBI-9b Trust/Board Action on Peer Reviews
That NHS Trusts and Health Boards should be required to deliberate on peer review findings and give favourable consideration to implementing the …
Infected Blood Inquiry (2024) Accepted
IBI-9c Five-Year Peer Review Cycle
A peer review of each centre should take place not less than once every five years.
Infected Blood Inquiry (2024) Accepted
IBI-9d Haemophilia Centre Resources
The necessary administrative and clinical resources should be provided by hospital trusts and boards, integrated care boards, and service commissioners to facilitate …
Infected Blood Inquiry (2024) Accepted
IBI-9e Recombinant Products Over Plasma-Derived
Recombinant coagulation factor products should be offered in place of plasma-derived ones where clinically appropriate. Service commissioners should ensure that such treatment …
Infected Blood Inquiry (2024) Accepted
IBI-9f National Haemophilia Database Support
That the National Haemophilia Database, run by the UKHCDO, merits the support of additional central funding.
Infected Blood Inquiry (2024) Accepted
IBI-10a(i) Patient Satisfaction in Clinical Audits
A clinical audit should as a matter of routine include measures of patient satisfaction or concern, and these should be reported to …
Infected Blood Inquiry (2024) Accepted
IBI-10a(ii) Charity Funding for Patient Advocacy
That the following charities receive funding specifically for patient advocacy: the UK Haemophilia Society; the Hepatitis C Trust; Haemophilia Scotland; the Scottish …
Infected Blood Inquiry (2024) Accepted
IBI-10a(iii) Additional Charity Support
That favourable consideration be given to other charities and organisations supporting people infected and affected that were granted core participant status (as …
Infected Blood Inquiry (2024) Accepted
IBI-10a(iv) Thalassaemia Society Support
Particular consideration be given, together with the UK Thalassaemia Society and the Sickle Cell Society, to how the needs of patients with …
Infected Blood Inquiry (2024) Accepted in Part
IBI-10a(v) Yellow Card System Prominence
Steps be taken to give greater prominence to the online Yellow Card system to those receiving drugs or biological products, or who …
Infected Blood Inquiry (2024) Accepted
IBI-11a Ministerial Power to Call Inquiries
That a minister should retain the power to call an inquiry as the minister sees fit, in accordance with the Inquiries Act …
Infected Blood Inquiry (2024) Accepted in Part
IBI-11b Parliamentary Referral to PACAC
If there is sufficient support from within Parliament for there to be an inquiry, the question whether there should be one should …
Infected Blood Inquiry (2024) Accepted in Part
IBI-11c PACAC Recommendation Power
If it appears to PACAC that there is sufficient concern to justify a public inquiry, either because what happened and why has …
Infected Blood Inquiry (2024) Accepted in Part
IBI-11d Ministerial Reasons for Disagreement
If the minister disagrees with the recommendation, they must set out in detail and publish reasons for this disagreement which are sufficient …
Infected Blood Inquiry (2024) Accepted in Part
IBI-12a Implementation Commitment Within 12 Months
Within the next 12 months, the Government should consider and either commit to implementing the recommendations which I make, or give sufficient …
Infected Blood Inquiry (2024) Accepted
IBI-12b Parliamentary Progress Report
During that period, and before the end of this year – the Government should report back to Parliament as to the progress …
Infected Blood Inquiry (2024) Accepted
IBI-12c No Delay to Second Interim Response
This timetable should not interfere with earlier consideration and response to the Recommendations of the Second Interim Report of the Inquiry.
Infected Blood Inquiry (2024) Accepted
IBI-12d PACAC Oversight of Implementation
The Public Administration and Constitutional Affairs Committee (“PACAC”) should review both the progress towards responding to the Inquiry’s recommendations and, to the …
Infected Blood Inquiry (2024) Accepted in Part
IBI-12e PACAC Role for Future Inquiries
PACAC should accept the role in respect of any future statutory inquiry of reviewing the government’s timetable for consideration of recommendations, and …
Infected Blood Inquiry (2024) Accepted in Part
IR1-1 Interim Compensation Payments
An interim payment, of no less than £100,000, should be paid to all those infected and all bereaved partners currently registered with …
Infected Blood Inquiry (2022) Accepted
IR2-1 Scheme Eligibility - Infected and Affected Persons
I recommend that the scheme should offer redress to those infected with HCV and/or HIV, and/or HBV (limited to chronic HBV unless …
Infected Blood Inquiry (2023) Accepted
IR2-2 Eligibility Conditions for Infected Persons
I recommend that the conditions of eligibility for admission of relevant infected persons to the scheme should be that: a) they have …
Infected Blood Inquiry (2023) Accepted
IR2-3 Standard of Proof and Automatic Eligibility
As above, save that (a) the last bullet point should read: "eligibility is accepted if the information available points towards eligibility and …
Infected Blood Inquiry (2023) Accepted
IR2-4 Affected Persons Categories
I recommend that the following relevant affected persons should be admitted to the scheme: a) spouses, civil partners and long term cohabitees …
Infected Blood Inquiry (2023) Accepted
IR2-5 Classification of Infections and Severity
I recommend that infections eligible for compensation should be classified in the following manner: a) there should be defined categories for each …
Infected Blood Inquiry (2023) Accepted
IR2-6 Categories of Loss and Award Heads
I recommend that the appropriate award in any case should be composed under the following categories of loss, applicable to both eligible …
Infected Blood Inquiry (2023) Accepted
IR2-7 No Exemplary Damages but Court Access Preserved
I recommend that there should be no award for exemplary damages, though it should remain open to a claimant to pursue such …
Infected Blood Inquiry (2023) Accepted
IR2-8 Tariff-Based Compensation Framework
I recommend that the Government should approve a scheme setting out a framework of tariff based compensation for eligible infected and affected …
Infected Blood Inquiry (2023) Accepted
IR2-9 Status of Awards and Legal Rights
I recommend that, with reference to the status of awards: a) eligible infected and affected persons should not be required to accept …
Infected Blood Inquiry (2023) Accepted
IR2-10 Form of Awards - Lump Sum and Periodical Payments
I recommend that: a) awards should be made in a lump sum in respect of an Injury Impact Award, Social Impact Award, …
Infected Blood Inquiry (2023) Accepted
IR2-11 Interest on Past Losses
I recommend that interest be payable on awards for past financial losses and past provision of care, from the date of infection …
Infected Blood Inquiry (2023) Accepted
IR2-12 Interim Payments for Bereaved Families
I recommend that an interim payment of £100,000 should be paid to recognise the deaths of people to date unrecognised and alleviate …
Infected Blood Inquiry (2023) Accepted
IR2-13 Relationship with Support Schemes and Benefits
I recommend that, with regard to the relationship between compensation, support payments and benefits: a) in assessing compensation under the scheme, no …
Infected Blood Inquiry (2023) Accepted
IR2-14 Arms Length Body Administration
I recommend that an Arms Length Body (ALB) should be set up to administer the compensation scheme, with guaranteed independence of judgement, …
Infected Blood Inquiry (2023) Accepted
IR2-15 Support Services for Applicants
I recommend that the scheme should include provision of the following support services to be provided without charge to the applicant: a) …
Infected Blood Inquiry (2023) Accepted
IR2-16 Central Delivery with Devolved Support
I recommend that the compensation scheme should be delivered by one central body, appropriately resourced and staffed. Current support schemes should however …
Infected Blood Inquiry (2023) Accepted
IR2-17 Bespoke Psychological Service
I recommend that without delay steps be taken to provide a bespoke psychological service in England.
Infected Blood Inquiry (2023) Accepted
‹ Prev Page 7 of 13 Next ›